Grace Bernaudo
Adult Health · Mineola, NYNPI 1750901229
Payments from drug & device makers
Across 51 payments — averaging $24.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$270
- Xeris Pharmaceuticals, Inc.$262
- Insulet Corporation$176
- Abbott$127
- Tandem Diabetes Care, Inc.$118
- Lilly USA, LLC$88
- plus $229 from 8 others
What the payments were for
- Food & beverage$1,270100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $270 |
| Xeris Pharmaceuticals, Inc. | 12 | $262 |
| Insulet Corporation | 7 | $176 |
| Abbott | 3 | $127 |
| Tandem Diabetes Care, Inc. | 3 | $118 |
| Lilly USA, LLC | 4 | $88 |
| Dexcom, Inc. | 2 | $44 |
| Verity Pharmaceuticals Inc. | 2 | $43 |
| BETA Bionics, Inc. | 1 | $37 |
| Amneal Pharmaceuticals LLC | 1 | $24 |
| Biotronik NRO, Inc. | 1 | $24 |
| Amgen | 1 | $19 |
| Boston Scientific | 1 | $19 |
| Bayer | 1 | $18 |
How this compares
$1,270 in reported general payments places this provider in the 70th percentile of 3,828 adult health providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 145 | $272,864 |
| MounjaroTirzepatide | 222 | $262,034 |
| JardianceEmpagliflozin | 60 | $83,800 |
| TrulicityDulaglutide | 50 | $75,383 |
| RybelsusSemaglutide | 37 | $57,433 |
| FarxigaDapagliflozin Propanediol | 26 | $39,319 |
| Tresiba Flextouch U-100Insulin Degludec | 46 | $39,317 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 15 | $24,815 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $22,680 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 31 | $14,099 |
| Novolog FlexpenInsulin Aspart | 51 | $13,743 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 66 | $8,654 |
| Humalog Kwikpen U-100Insulin Lispro | 22 | $7,627 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 16 | $6,862 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $6,523 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $88 | $337,417272 claims |
| Novo NordiskOzempic, Rybelsus | $270 | $330,297182 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $24 | $71138 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,828 adult health providers in New York.
Other adult health in Mineola
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.